Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery
AWS News, Wednesday, July 10th, 2024
State-of-the-art platform, built using Amazon Web Services technologies, integrates generative AI drug design and robotic lab automation to further accelerate Exscientia's ability to deliver high quality drug candidates at faster speed and lower cost
Exscientia announced it will be expanding its work with Amazon Web Services (AWS) to use the cloud provider's artificial intelligence (AI) and machine learning (ML) services to power its platform for end-to-end drug discovery and automation.